Steps to Implementing a Quality Management System
Steps to Implementing a Quality Management System Making quality not just an expectation, but an intrinsic and foundational element of […]
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor?
Diversity and Inclusion: Who is Responsible – Site, CRO or Sponsor? Attaining a diverse trial patient population is crucial to
End-to-End Approach to Clinical Development
This white paper promotes an end-to-end approach through discussing Organizational design, Team structure, Process design, and Talent development programs.
Effective Clinical Trial Financial Management Post-Pandemic
Explore strategies for post-pandemic clinical trial financial management, from cost recovery to adapting to evolving participant expectations.
Understanding the Current and Future States of Cell and Gene Therapy Research
Explore the current and future landscape of gene therapy research, from advancements in oncology to strategies for improving review efficiency.
Vendor Management and Oversight of Clinical Trials
Discover practical guidance on vendor management, including vendor selection, risk assessment, and oversight to ensure trial success.
Study Activation Survey Results and What it Means for Sites
In this episode, Jake Meyer and Candi Barlow review results from Advarra’s recent survey and discuss study activation success strategies for sites.
Site Technology Guide for Facilitating GCP in Decentralized Trials
Explore GCP considerations for decentralized trials and discover how secure site technology can streamline oversight and management.
IBC Overview eLearning Module
Learn the essentials of institutional biosafety committees (IBCs), their role in research, and how they differ from IRBs in this eLearning module.
Developing a Data Strategy for Clinical Trials
This white paper outlines a data strategy specific to an organization’s unique needs and allows for adjustments as the organization grows and evolves.
Improving Access to Research for Diverse and Underserved Populations
Discover expert insights on enhancing research inclusivity through improved access, stakeholder relationships, and measurable strategies.
The State of Clinical Trial Activation at Sites
Study activation is a necessary part of a clinical trial but can be rather difficult to coordinate efficiently. There is